MedPath

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

Not Applicable
Active, not recruiting
Conditions
Breast Cancer
Interventions
Other: educational intervention
Other: questionnaire administration
Other: counseling intervention
Other: survey administration
Procedure: quality-of-life assessment
Registration Number
NCT01450020
Lead Sponsor
City of Hope Medical Center
Brief Summary

This randomized clinical trial studies peer navigator education in improving survivorship care in African American breast cancer survivors. An educational intervention involving peer groups may help to improve the well-being and quality of life (QOL) in breast cancer survivors

Detailed Description

PRIMARY OBJECTIVES:

I. To evaluate the ability of peer navigation (PN) to improve understanding of survivorship care planning (SCP) at 6 months.

II. To promote adherence to the SCP schedule of follow-up examinations at 12 months.

SECONDARY OBJECTIVES:

I. To evaluate the effect of PN on change from baseline in medical efficacy, preparedness for life as new survivor, and physical and health related QOL at 6 months.

OUTLINE: PNs are trained on medical issues and resources, and SCP. Participants are then randomized to 1 of 2 treatment arms.

ARM I: Participants receive 4 PN sessions tailored to their needs followed by a 6 month booster session and American Cancer Society (ACS) materials.

ARM II: Participants receive ACS materials.

After completion of study treatment, patients are followed up at 6 and 12 months.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
145
Inclusion Criteria
  • TRIAL SUBJECTS:
  • Patient age 18 years or older who self-identifies as African-American
  • In early survivorship phase, defined as being 1-12 months post completion of treatment for stage 0-3 breast cancer
  • Receiving health care primarily through an health maintenance organization (HMO)
  • Patients with metastatic cancer or a second primary cancer, because their medical characteristics (e.g. disease progression) are significantly different
  • Breast cancer survivors (BCS) with other major disabling medical, psychiatric, or substance abuse conditions (e.g., anxiety, depression, alcohol/tobacco problems) will be excluded
  • PEER NAVIGATORS:
  • At least 25 years of age who self-identifies as African-American
  • Previously participated in any type of research study
  • Has at least high school education
  • Has been diagnosed with breast cancer, currently in remission or eradicated
  • Belongs to a breast cancer support group
  • Has a valid driver's license
  • Owns an operational vehicle
  • Has access to a personal computer with internet access
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm I (PN and ACS material)questionnaire administrationParticipants receive 4 PN sessions tailored to their needs followed by a 6 month booster session and ACS materials.
Arm I (PN and ACS material)counseling interventionParticipants receive 4 PN sessions tailored to their needs followed by a 6 month booster session and ACS materials.
Arm II (ACS material)questionnaire administrationParticipants receive ACS materials only.
Arm I (PN and ACS material)educational interventionParticipants receive 4 PN sessions tailored to their needs followed by a 6 month booster session and ACS materials.
Arm I (PN and ACS material)quality-of-life assessmentParticipants receive 4 PN sessions tailored to their needs followed by a 6 month booster session and ACS materials.
Arm II (ACS material)survey administrationParticipants receive ACS materials only.
Arm II (ACS material)quality-of-life assessmentParticipants receive ACS materials only.
Arm I (PN and ACS material)survey administrationParticipants receive 4 PN sessions tailored to their needs followed by a 6 month booster session and ACS materials.
Arm II (ACS material)educational interventionParticipants receive ACS materials only.
Primary Outcome Measures
NameTimeMethod
Adherence to the SCP schedule of follow-up examinationsAt 12 months

Measured using a newly created, 50-point scale that gives equal weight to completion of the recommended: physical exams, imaging, pelvic exam, annual oncology visit, and breast self-exams.

Ability of peer navigation to improve understanding of SCPAt 6 months

Chi-square and t-tests will be used to compare the baseline characteristics of subjects randomized to PN intervention vs control. For subjects in the intervention arm, the number of navigation sessions received will be reported, and correlated factors will be explored. The number of subjects navigated per PN will also be reported. Nonevaluable and evaluable subjects (defined at 6 and 12 months) will be compared. Site of care will be handled as a cluster level variable in generalized linear mixed (GLM) regression models.

Secondary Outcome Measures
NameTimeMethod
Physical and health related QOLAt 6 months
Preparedness for life as new survivor (PLANS)At 6 months

PLANS consists of two subscales that measure patients' knowledge and self efficacy with regards to their Access and Quality of Survivorship Care Plan (SCP) and adherence with regard to following these tasks. The knowledge subscale (Cronbach's alpha 0.90) and adherence subscale (Cronbach's alpha 0.70) have good reliability.

Effect of PN on change in medical efficacyBaseline to 6 months

Exploratory analyses will analyze the effect of PN intervention actually received, using the number of PN sessions completed and the quality of the subject's PN as measured by PN's post-training level of acuity and utility.

Trial Locations

Locations (1)

City of Hope Medical Center

🇺🇸

Duarte, California, United States

© Copyright 2025. All Rights Reserved by MedPath